Ładuje się......
Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
Several second-generation bisphosphonates (BPs) are approved in osteoporosis treatment. Efficacy and safety depends on potency of farnesyl pyrophosphate synthase (FPPS) inhibition, hydroxyapatite affinity, compliance and adherence. The latter may be influenced by frequency and route of administratio...
Zapisane w:
| Wydane w: | Int J Womens Health |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4274146/ https://ncbi.nlm.nih.gov/pubmed/25565901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S73944 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|